- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Plasma Insulin in Japan
Total 159 results
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration Change of QuetiapineJapan
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
Tottori University HospitalCompleted
-
Kumamoto UniversityCompleted
-
Fresenius Kabi JapanCompletedPlasma Volume Substitution (Hypovolemia) Including Massive HemorrhageJapan
-
Kochi UniversityCompleted
-
Kagoshima UniversityUnknown
-
Aichi Gakuin UniversityCompletedInflammation | Metabolic Syndrome | Oxidative StressJapan
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Aichi Gakuin UniversityUnknownMetabolic Syndrome | Periodontal DiseaseJapan
-
TakedaCompleted
-
Janssen Pharmaceutical K.K.CompletedMultiple MyelomaJapan
-
Janssen Pharmaceutical K.K.Completed
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
CelgeneCompleted
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
Nagoya UniversityUnknownHypertension | Healthy | Diabetes Mellitus | Hyperlipidemia | Metabolic Syndrome XJapan
-
Osaka UniversityUnknownDiabetes Mellitus, Type 2Japan
-
Bristol-Myers SquibbCompleted
-
Toujinkai HospitalCompletedCoronary Artery Disease | Hemodialysis | Kidney DiseaseJapan
-
GlaxoSmithKlineActive, not recruiting
-
TakedaCompletedEssential Hypertension Complicated by Type 2 Diabetes MellitusJapan
-
Eli Lilly and CompanyCompleted
-
SymBio PharmaceuticalsTerminated
-
Janssen Pharmaceutical K.K.Completed
-
Novartis PharmaceuticalsTerminatedNeoplasms, HaematologicJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.TerminatedMultiple MyelomaJapan
-
Bristol-Myers SquibbCompleted
-
PfizerActive, not recruitingRelapsed or Refractory Multiple MyelomaJapan
-
Cutera Inc.CompletedMelasma | LentiginesChina, Japan
-
PfizerActive, not recruitingLymphoma | Multiple MyelomaJapan
-
CelgeneCompleted
-
CelgeneCompletedMyelodysplastic Syndromes | Multiple MyelomaJapan
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Bristol-Myers SquibbAbbVieNo longer available
-
Genzyme, a Sanofi CompanyCompleted
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
Otsuka Pharmaceutical Co., Ltd.RecruitingMultiple Myeloma (MM)Japan
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)Japan
-
CelgeneCompleted
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan